LenioBio logo

LenioBio

Rapid eukaryotic, cell-free protein expression that scales for research, development and production.

49 employees · est. 2016 · Dusseldorf, Germany

VS
SYNTHELIS logo

SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !

10 employees · est. 2011 · Grenoble, France

SYNTHELIS is the older company (2016 vs 2011); LenioBio is the larger of the two.

Side-by-Side Comparison

LenioBio SYNTHELIS
Founded
2016 2011 older
Headquarters
Dusseldorf, Germany Grenoble, France
Employees
49 larger 10
Industry
Biotechnology Biotechnology, Health Care, Manufacturing
Funding Stage
Grant Series Unknown
Total Funding
$14.25M $610.00K
Funding Rounds
3 1
Services
Not tracked yet Expression of Proteins in Cell-Free Systems, Expression of Proteins in E. coli, Bioluminescence Products and Services
Target Customers
Not tracked yet Biopharmaceutical Industry, Biotechnology Companies, Diagnostic Laboratories, Academic Research Institutions
Taxonomy
Protein Expression, Protein Production, Synthetic Biology, Membrane Proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free Protein Production, Plant-based Protein, Innovation Cycles Cell-Free Systems, Protein Expression, Membrane Proteins, Proteoliposomes, Detergent Format, Pharmaceutical Services, Biotech, Vaccine Development, Screening Technologies, Antibody Development, In Vitro Diagnostics, Structural Biology, Protein Purification, Therapeutic Proteins, Synthetic Biology
Website
leniobio.com synthelis.com
LenioBio logo

About LenioBio

LenioBio, a biotechnology startup headquartered in Germany, was founded in 2016. The company's mission is to revolutionize the production of medicines and food by developing efficient, robust, and sustainable technologies. LenioBio specializes in rapid eukaryotic, cell-free protein expression that s...

SYNTHELIS logo

About SYNTHELIS

SYNTHELIS is a French biotech company based in Grenoble, at the heart of the French Alps, pioneering in Cell-Free systems. Established in 2011, it has become a benchmark in Europe with its proprietary cell-free expression technology and is now positioned to compete with US leaders in the field. The...

We will tell you when either one moves

BounceWatch watches LenioBio and SYNTHELIS for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at LenioBio and SYNTHELIS — by email.

Frequently Asked Questions

LenioBio — Rapid eukaryotic, cell-free protein expression that scales for research, development and production.. SYNTHELIS — Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
LenioBio has raised $14.25M while SYNTHELIS has raised $610.00K.
LenioBio and SYNTHELIS operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare LenioBio with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at LenioBio on 11 Sep 2024, and SYNTHELIS on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy